Phil Davies

Phil Davies is an experienced leader in the biopharmaceutical industry, currently serving as the President of North America and Global Head of Scientific and Strategic Affairs at Biotrial since September 2017. Previously, Phil held various leadership positions at Takeda Pharmaceuticals, including Senior Director of Companion Diagnostics Co-Development and Director of Category Management. Phil's extensive background also includes roles at Millennium - The Takeda Oncology Company, Novum Pharmaceutical Research Services, Kendle International, and Eli Lilly, where responsibilities spanned clinical operations, program management, and strategic business development. Phil began a professional career at Covance and has a strong academic foundation with a BSc (Hons) in Biological Sciences from The Manchester Metropolitan University and further education from Harvard Law School.